Your browser doesn't support javascript.
loading
Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn's disease.
Cheung, Tik Shing; Giacomini, Chiara; Cereda, Matteo; Avivar-Valderas, Alvaro; Capece, Daria; Bertolino, Giuliana Minani; delaRosa, Olga; Hicks, Ryan; Ciccocioppo, Rachele; Franzoso, Guido; Galleu, Antonio; Ciccarelli, Francesca D; Dazzi, Francesco.
Afiliación
  • Cheung TS; School of Cancer and Pharmacological Sciences, King's College London, London, UK.
  • Giacomini C; School of Cancer and Pharmacological Sciences, King's College London, London, UK; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.
  • Cereda M; Department of Biosciences, Università degli Studi di Milano, Via Celoria 26, 20133 Milan, Italy; Italian Institute for Genomic Medicine, c/o IRCCS, Str. Prov.le 142, km 3.95, 10060 Candiolo, TO, Italy.
  • Avivar-Valderas A; Takeda Madrid, Cell Therapy Technology Center, Tres Cantos, Spain.
  • Capece D; Centre for Molecular Immunology and Inflammation, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Bertolino GM; School of Cancer and Pharmacological Sciences, King's College London, London, UK.
  • delaRosa O; Takeda Madrid, Cell Therapy Technology Center, Tres Cantos, Spain.
  • Hicks R; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK; BioPharmaceuticals R&D Cell Therapy, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ciccocioppo R; Gastroenterology Unit, Department of Medicine, A.O.U.I. Policlinico G.B. Rossi & University of Verona, Verona, Italy.
  • Franzoso G; Centre for Molecular Immunology and Inflammation, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Galleu A; School of Cancer and Pharmacological Sciences, King's College London, London, UK.
  • Ciccarelli FD; School of Cancer and Pharmacological Sciences, King's College London, London, UK; Cancer Systems Biology Laboratory, The Francis Crick Institute, London, UK.
  • Dazzi F; School of Cancer and Pharmacological Sciences, King's College London, London, UK; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK; BioPharmaceuticals R&D Cell therapy, AstraZeneca, Cambridge, UK. Electronic address: francesco.dazzi@kcl.ac.uk.
Mol Ther ; 31(12): 3531-3544, 2023 Dec 06.
Article en En | MEDLINE | ID: mdl-37805713
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido